SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-18-001715
Filing Date
2018-02-13
Accepted
2018-02-13 17:08:01
Documents
1
Group Members
NEIL WOODFORD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13G sc13g0218a4wood_thera.htm SC 13G/A 112478
  Complete submission text file 0001213900-18-001715.txt   114133
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 18604683
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 00 44 1865809023
Woodford Investment Management Ltd (Filed by) CIK: 0001634557 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A